» Articles » PMID: 28160100

Healthcare Utilization and Costs in Primary Care Patients with Dementia: Baseline Results of the DelpHi-trial

Overview
Specialty Health Services
Date 2017 Feb 5
PMID 28160100
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The objectives of this cross-sectional analysis were to determine healthcare resource utilization and cost for community-dwelling patients with dementia (PWD) from a payer's and societal perspective, and to analyze the associations between costs and sociodemographic and clinical variables. Analysis of healthcare costs from a payer's perspective was based on a sample of 425 PWD, analysis of healthcare costs from societal perspective on a subsample of 254 PWD and their informal caregivers. Frequency of healthcare resource utilization was assessed by means of questionnaires. Informal care and productivity losses were assessed by using the Resource Utilization in Dementia questionnaire (RUD). Costs were monetarized using standardized unit costs. To analyze the associations, multiple linear regression models were used. Total annual costs per PWD valued 7016€ from a payer's and 25,877€ from a societal perspective, meaning that societal cost is approximately three and a half times as much as payer's expenditures. Costs valuated 5456 € for medical treatments, 1559 € for formal care, 18,327€ for informal care. Productivity losses valued 1297€ for PWD caregivers. Informal care could vary substantially (-21%; +33%) concerning different valuation methods. Medical care costs decreased significantly with progression of dementia and with age. Costs of care double over the stages of dementia. Formal care costs were significantly higher for PWD living alone and informal care costs significantly lower for PWD with an employed caregiver. For all cost categories, deficits in daily living activities were major cost drivers.

Citing Articles

Comparing Different Implementation Strategies for Collaborative Dementia Care Management in Terms of Patients' Characteristics, Unmet Needs, and the Impact on Quality of Life and Costs in Germany.

Platen M, Hoffmann W, Michalowsky B Pharmacoecon Open. 2024; 9(2):271-282.

PMID: 39674842 PMC: 11865390. DOI: 10.1007/s41669-024-00548-w.


The formal care costs of dementia: a longitudinal study using Swedish register data.

Zilling J, Gerdtham U, Jarl J, Saha S, Persson S Eur J Health Econ. 2024; .

PMID: 39080093 DOI: 10.1007/s10198-024-01707-w.


Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care: A Secondary Analysis of a Cluster Randomized Clinical Trial.

Michalowsky B, Blotenberg I, Platen M, Teipel S, Kilimann I, Portacolone E JAMA Netw Open. 2024; 7(7):e2419282.

PMID: 38967926 PMC: 11227088. DOI: 10.1001/jamanetworkopen.2024.19282.


Feedback System Analysis of a Multicomponent Intervention on Dyads of Home-Dwelling Persons With Dementia and Their Caregivers: Results From the LIVE@Home.Path Trial.

Vislapuu M, Patrascu M, Allore H, Husebo B, Kjerstad E, Gedde M Innov Aging. 2024; 8(3):igae020.

PMID: 38550899 PMC: 10976912. DOI: 10.1093/geroni/igae020.


The Economic Costs of Informal Care: Estimates from a National Cross-Sectional Survey in The Netherlands.

Elayan S, Angelini V, Buskens E, de Boer A Eur J Health Econ. 2024; 25(8):1311-1331.

PMID: 38294595 PMC: 11442538. DOI: 10.1007/s10198-023-01666-8.


References
1.
Mackin R, Ayalon L, Feliciano L, Arean P . The sensitivity and specificity of cognitive screening instruments to detect cognitive impairment in older adults with severe psychiatric illness. J Geriatr Psychiatry Neurol. 2010; 23(2):94-9. PMC: 3239217. DOI: 10.1177/0891988709358589. View

2.
Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J . Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology. 2006; 67(12):2186-91. DOI: 10.1212/01.wnl.0000249311.80411.93. View

3.
Quentin W, Riedel-Heller S, Luppa M, Rudolph A, Konig H . Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand. 2009; 121(4):243-59. DOI: 10.1111/j.1600-0447.2009.01461.x. View

4.
Michalowsky B, Eichler T, Thyrian J, Hertel J, Wucherer D, Hoffmann W . Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany?. Int Psychogeriatr. 2015; 28(3):359-69. DOI: 10.1017/S1041610215001453. View

5.
Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H . The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord. 1998; 9 Suppl 2:20-6. DOI: 10.1159/000051195. View